Sotorasib靶向治疗<em> KRAS</em>G12C突变晚期实体肿瘤的疗效及安全性

Sotorasib靶向治疗 KRASG12C突变晚期实体肿瘤的疗效及安全性

评价者：曹小龙¹, 文献合成者：曾康辉²

Efficacy and Safety of Sotorasib in Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

Reviewer：CAO Xiao-long¹, Literature Co-worker： ZENG Kang-hui²